Loading...
XSHE300869
Market cap708mUSD
Jan 10, Last price  
12.93CNY
1D
-3.44%
1Q
-17.85%
IPO
-90.70%
Name

Contec Medical Systems Co Ltd

Chart & Performance

D1W1MN
XSHE:300869 chart
P/E
31.34
P/S
6.96
EPS
0.41
Div Yield, %
1.32%
Shrs. gr., 5y
2.58%
Rev. gr., 5y
15.55%
Revenues
747m
+4.89%
213,586,877252,132,186284,431,140442,091,847397,804,536362,655,145387,246,6941,401,225,344908,712,161712,114,538746,902,140
Net income
166m
-15.51%
53,790,20854,461,14661,533,546103,492,93977,057,16062,030,95073,781,193613,395,380352,353,389196,202,558165,765,985
CFO
181m
+74.63%
74,408,56236,454,33035,229,300130,642,200117,613,95829,806,06250,218,275597,733,5714,647,412103,656,852181,014,720
Dividend
May 29, 20240.3 CNY/sh
Earnings
May 16, 2025

Profile

Contec Medical Systems Co.,Ltd engages in the research, manufacture, and distribution of medical instruments. The company's products include electronic sphygmomanometers, ambulatory blood pressure monitors, pulse oximeters, monitors, stethoscopes, simulators, analyzers, nebulizers, ultrasound equipment, oxygen concentrators, predictive thermometers, syringe and infusion pumps, and EMG/EP systems; ECG monitors and workstations; and EEG, pulmonary function, home, telemedicine, veterinary, electronic colposcopy, and Capnography related products. It sells its products through distributors in China and internationally. The company was founded in 1992 and is based in Qinhuangdao, China.
URL
https://www.contecmed.com.cn/
IPO date
Aug 24, 2020
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
746,902
4.89%
712,115
-21.63%
Cost of revenue
579,590
570,966
Unusual Expense (Income)
NOPBT
167,312
141,149
NOPBT Margin
22.40%
19.82%
Operating Taxes
20,360
23,192
Tax Rate
12.17%
16.43%
NOPAT
146,952
117,957
Net income
165,766
-15.51%
196,203
-44.32%
Dividends
(68,696)
(120,539)
Dividend yield
0.80%
0.91%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
347,000
905,042
Long-term debt
701,005
675,052
Deferred revenue
9,067
Other long-term liabilities
8,923
1
Net debt
(915,363)
121,668
Cash flow
Cash from operating activities
181,015
103,657
CAPEX
(30,736)
Cash from investing activities
(830,623)
Cash from financing activities
(383,439)
781,338
FCF
605,883
(268,600)
Balance
Cash
1,963,368
1,439,332
Long term investments
19,094
Excess cash
1,926,023
1,422,820
Stockholders' equity
1,699,975
1,583,513
Invested Capital
1,399,033
2,055,018
ROIC
8.51%
5.82%
ROCE
5.40%
4.04%
EV
Common stock shares outstanding
414,415
408,755
Price
20.63
-36.66%
32.57
-19.68%
Market cap
8,549,381
-35.78%
13,313,161
-18.29%
EV
7,634,018
13,434,829
EBITDA
194,834
160,204
EV/EBITDA
39.18
83.86
Interest
45,103
19,080
Interest/NOPBT
26.96%
13.52%